Press Releases
New BIO Analysis Reveals Declining Pain Drug…
Today, the Biotechnology Innovation Organization (BIO) released a new analysis showing that the current level of investment in new pain and addiction treatments is falling short of what is needed to combat the mounting public health crises.
The…
Groups Call on North American Leaders to Follow…
The governments of Mexico, Canada and the United States should look to the framework in the U.S.-Mexico-Canada Agreement to continue growing the complementary trade and integrated markets throughout North America, agriculture-related associations…
Optimize your time and investment by downloading…
VANCOUVER, BC, CANADA, and WASHINGTON, DC, UNITED STATES, Dec. 12, 2022 – Today, Novateur Ventures, a leading global life sciences advisory firm and Biotechnology Innovation Organization (BIO), the world's largest advocacy association for…
Letters, Testimony, & Comments
Ag Biotech Alliance Response to Biotech RFI
ABA has submitted comments to the Office of Science & Technology Policy on how regulations underpinning the Coordinated Framework for the Regulation of Biotechnology can better facilitate the use of biotechnology to stimulate the economy…
BIO Response to Biotech RFI
BIO has submitted comments to the Office of Science & Technology Policy on how regulations underpinning the Coordinated Framework for the Regulation of Biotechnology can better facilitate the use of biotechnology to stimulate the economy…
BIO comments to USTR on the Agency’s 2023 Special…
Amicus Briefs
BIO Files Amicus Brief in Petition for a Writ of…
BIO and AUTM have filed an amicus brief in petition for a writ of certiorari the in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States. BIO and AUTM are concerned that…
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology.
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
Blog Posts